Valuation (47%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 20.64 | N/A |
| PEG Ratio (TTM) | -0.46 | N/A |
| P/S Ratio (TTM) | 3.17 | N/A |
| P/B Ratio (TTM) | 0.86 | N/A |
| P/FCF Ratio (TTM) | 7.36 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.34% | N/A |
| ROE (TTM) | 2.98% | N/A |
| Net Profit Margin (TTM) | 14.46% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (52%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 7,380.50% | 99.25% | N/A |
| Revenue | -8.42% | 220.31% | N/A |
| Net Income | 7,570.79% | 138.75% | N/A |
| Cash Flow | 0.98% | 241.39% | N/A |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.19 | N/A |
| Quick Ratio (TTM) | 4.19 | N/A |
| D/E Ratio (TTM) | 0.72 | N/A |
| Interest Coverage (TTM) | 3.76 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.68 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |